0001178913-19-001082.txt : 20190408
0001178913-19-001082.hdr.sgml : 20190408
20190408161330
ACCESSION NUMBER: 0001178913-19-001082
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190408
FILED AS OF DATE: 20190408
DATE AS OF CHANGE: 20190408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BEN-YORAM ISRAEL
CENTRAL INDEX KEY: 0001320556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31392
FILM NUMBER: 19737588
MAIL ADDRESS:
STREET 1: 24 BARKAN STREET
CITY: RISHON LEZION
STATE: L3
ZIP: 00000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PLURISTEM THERAPEUTICS INC
CENTRAL INDEX KEY: 0001158780
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 980351734
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: MATAM ADVANCED TECHNOLOGY PARK
STREET 2: BUILDING NO. 5
CITY: HAIFA
STATE: L3
ZIP: 3508409
BUSINESS PHONE: 972-74-710-7171
MAIL ADDRESS:
STREET 1: MATAM ADVANCED TECHNOLOGY PARK
STREET 2: BUILDING NO. 5
CITY: HAIFA
STATE: L3
ZIP: 3508409
FORMER COMPANY:
FORMER CONFORMED NAME: PLURISTEM LIFE SYSTEMS INC
DATE OF NAME CHANGE: 20030701
FORMER COMPANY:
FORMER CONFORMED NAME: AI SOFTWARE INC
DATE OF NAME CHANGE: 20010906
4
1
zk1922906.xml
OWNERSHIP DOCUMENT
X0306
4
2019-04-08
0
0001158780
PLURISTEM THERAPEUTICS INC
PSTI
0001320556
BEN-YORAM ISRAEL
MATAM PARK, BUILDING #5
HAIFA
L3
3508409
ISRAEL
1
0
0
0
Common Stock
2019-04-08
4
P
0
71429
0.70
A
387235
D
Common Stock
411250
I
By Eshed Dash Ltd.
Common Stock Warrant
0.70
2019-04-08
4
P
0
71429
0
A
2019-04-08
2024-04-08
Common Stock
71429
71429
D
The common stock and common stock warrant were acquired in the issuer's public underwritten offering of units, in which each unit consisted of one share of common
stock and an accompanying common stock warrant to purchase one share of common stock, at a price of $0.70 per unit. The price paid per unit is reflected in Table I.
The common stock warrants were exercisable immediately upon their issuance.
/s/ Israel Ben-Yoram
2019-04-08